Media Contact: Lauren Jennings and Don Williams
Glodow Nead Communications; GreenwichRxPR@glodownead.com
FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx for another pharmacy, Clove Rx. For a complete list of affected products and lots, see the link below. The products are being recalled due to a potential lack of sterility assurance. These concerns arose following an inspection of the pharmacy by the FDA and Greenwich Rx’s evaluation of the affected products.
Risk Statement: Use of a drug product intended to be sterile, that is not sterile, could result in serious infections, which may be life threatening. Greenwich Rx has not identified any evidence of contamination in the recalled products; however, Greenwich Rx is initiating this recall as a precautionary measure, and you should follow all instructions below. To date, Greenwich Rx has not received any reports of adverse events related to this recall.
The affected products were dispensed nationwide between August 10, 2026 and September 21, 2026. A list of affected products, lot numbers, and beyond-use dates (expiration dates) is available at https://greenwichrx.org/news/general-recall-2026-11. Customers of Greenwich Rx and Clove Rx should compare the information on their medication labels with this list of affected products to confirm whether their medication is part of the recall.
| BPC-157 Injection | 3mg/mL | 5mL | 0019-082526-1 | 12/03/2026 | Greenwich Rx |
| BPC-157/TB-500 Injection | 3mg/3mg/mL | 5mL | 0022-082026-1 | 11/28/2026 | Greenwich Rx |
| BPC-157/TB-500 Injection | 3mg/3mg/mL | 5mL | 0022-082726-1 | 12/05/2026 | Greenwich Rx |
| BPC-157/TB-500 Injection | 3mg/3mg/mL | 5mL | 0022-090226-1 | 12/11/2026 | Greenwich Rx |
| BPC-157/TB-500 Injection | 3mg/3mg/mL | 5mL | 0022-090426-1 | 12/13/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu Injection | 3mg/3mg/10mg/mL | 5mL | 0105-081026-1 | 11/18/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu Injection | 3mg/3mg/10mg/mL | 5mL | 0105-090226-1 | 12/11/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu Injection | 3mg/3mg/10mg/mL | 5mL | 0105-090426-1 | 12/13/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu/KPV Injection | 3mg/3mg/10mg/3mg/mL | 5mL | 0020-082626-1 | 12/04/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu/KPV Injection | 3mg/3mg/10mg/3mg/mL | 5mL | 0020-090326-1 | 12/12/2026 | Greenwich Rx |
| BPC-157/TB-500/GHK-Cu/KPV Injection | 3mg/3mg/10mg/3mg/mL | 5mL | 0020-091026-1 | 12/19/2026 | Greenwich Rx |
| BPC-157/TB-500/KPV Injection | 3mg/3mg/3mg/mL | 5mL | 0021-081326-1 | 11/21/2026 | Greenwich Rx |
| BPC-157/TB-500/KPV Injection | 3mg/3mg/3mg/mL | 5mL | 0021-081426-1 | 11/22/2026 | Greenwich Rx |
| BPC-157/TB-500/KPV Injection | 3mg/3mg/3mg/mL | 5mL | 0021-082026-1 | 11/28/2026 | Greenwich Rx |
| BPC-157/TB-500/KPV Injection | 3mg/3mg/3mg/mL | 5mL | 0021-082626-1 | 12/04/2026 | Greenwich Rx |
Greenwich Rx is notifying its affected customers of this voluntary recall by mail. Customers who received medications through Clove Rx should review the affected product list, even if they have not received a direct recall notification. Greenwich Rx encourages those customers to contact Sedgwick using the information below if they have any questions about whether a product received through Clove Rx is included in the recall.
Consumers and clinics that have a product being recalled should stop use of the product immediately and discard it. Information regarding safe disposal of unused medicines is available at FDA.gov/DrugDisposal.
Adverse reactions or quality problems experienced with the use of the products may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.